1. Home
  2. CNXC vs OGN Comparison

CNXC vs OGN Comparison

Compare CNXC & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Concentrix Corporation

CNXC

Concentrix Corporation

HOLD

Current Price

$24.03

Market Cap

1.7B

Sector

Technology

ML Signal

HOLD

Logo Organon & Co.

OGN

Organon & Co.

HOLD

Current Price

$13.54

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNXC
OGN
Founded
1991
1923
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.5B
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
CNXC
OGN
Price
$24.03
$13.54
Analyst Decision
Strong Buy
Hold
Analyst Count
5
5
Target Price
$54.80
$11.40
AVG Volume (30 Days)
2.1M
2.3M
Earning Date
03-24-2026
05-07-2026
Dividend Yield
5.79%
0.60%
EPS Growth
N/A
N/A
EPS
1.20
0.55
Revenue
$9,825,771,000.00
$6,216,000,000.00
Revenue This Year
$5.29
$0.45
Revenue Next Year
$2.49
$1.67
P/E Ratio
$19.67
$24.64
Revenue Growth
2.15
N/A
52 Week Low
$19.12
$5.69
52 Week High
$62.14
$13.60

Technical Indicators

Market Signals
Indicator
CNXC
OGN
Relative Strength Index (RSI) 43.45 72.77
Support Level $22.05 $10.05
Resistance Level $34.64 N/A
Average True Range (ATR) 1.92 0.06
MACD -0.18 -0.05
Stochastic Oscillator 54.11 76.19

Price Performance

Historical Comparison
CNXC
OGN

About CNXC Concentrix Corporation

Concentrix Corp is a technology and services company. It designs, implements, and manages end-to-end solutions, including customer experience process optimization, technology development and design engineering, front- and back-office automation, analytics, and business transformation services. The company serves clients across multiple industry verticals, helping them manage customer engagement and operational processes throughout the customer lifecycle. The company operates in a single operating segment. It generates revenue through the provision of technology and services under contractual arrangements. Geographically, the company generates the maximum revenue from the Philippines and the rest from India, the United States, Great Britain, Germany, Canada and Other countries.

About OGN Organon & Co.

Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.

Share on Social Networks: